As an upregulated oncogenic lncRNA in ovarian cancers, silencing TMPO-AS1 or miR-200c overexpression decreases the migration and invasion of ovarian cancer cells both in vivo and in vitro (Li et al., 2020[63]). This evidence concerns the gene TMPO and ovarian carcinoma.